# Fate Therapeutics Inc: Form 8-K/A, filed Jun 17, 2025

- Company: [Fate Therapeutics Inc](/companies/fate.md) (CIK 1434316)
- Form: 8-K/A
- Filed: 2025-06-17
- Accepted by EDGAR: Jun 17, 2025, 16:01 ET
- Period: 2025-05-29
- Accession: 0001193125-25-142037
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1434316/000119312525142037/d35713d8ka.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1434316/000119312525142037/

## Items reported

- Item 5.07: Shareholder vote results

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1434316/000119312525142037/d35713d8ka.htm

Filed Jun 17, 2025.
Source: SEC EDGAR, the filing index for accession 0001193125-25-142037. Last ingested by Listed: Nov 14, 2026, 10:50 ET. No prices; not investment advice.
